These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1578911)

  • 1. Minimal residual disease in leukemia: state of the art 1991.
    Hagenbeek A
    Leukemia; 1992; 6 Suppl 2():12-6. PubMed ID: 1578911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
    Martens AC; Hagenbeek A
    Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A; Martens AC
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimum residual leukemic cells in genetically marked brown Norway rat myelocytic leukemia model].
    Yan Y; Martens AC; Van Bekkum DW
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):414-7. PubMed ID: 1304472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
    Martens AC; van Bekkum DW; Hagenbeek A
    Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
    Arkesteijn GJ; Martens AC; Jonker RR; Hagemeijer A; Hagenbeek A
    Cytometry; 1987 Nov; 8(6):618-24. PubMed ID: 3480794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
    Deptała A; Widzyńska I; Kuratowska Z
    Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Dominietto A
    Curr Opin Hematol; 2011 Nov; 18(6):381-7. PubMed ID: 21986564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
    Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A
    Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal residual disease in leukemia].
    Morishima Y
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2063-9. PubMed ID: 1888177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.
    van Bekkum DW; van Oosterom P; Dicke KA
    Cancer Res; 1976 Mar; 36(3):941-6. PubMed ID: 1062232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
    Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
    Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
    Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.